| Use of IUCD |
Bacterial Vaginosis (+ve) |
Healthy controls (-ve) |
p-value |
OR ( 95%CI) |
| n(%) |
n (%) |
| Absence of IUCD |
89 (70.6) |
144 (82.8) |
- |
1(Reference) |
| Presence of IUCD |
37 (29.4) |
30 (17.2) |
0.017 |
1.70( 1.1-2.6) # |
| Use of contraception |
| Absence of contraception |
105(83.33) |
119(68.39) |
- |
1(Reference) |
| Presence of contraception |
21(16.6) |
55(31.61) |
0.11 |
0.62 (0.34-1.11) # |
| STD in partners |
| Absence of STD in partners |
114(90.5) |
172(98.9) |
- |
1(Reference) |
| Presence of STD in partners |
12 (9.5) |
2 (1.1) |
0.001 |
8.28(1.8-36.3) # |
|
| # Absence of IUCD, Use of contraception and STD in partners were taken as reference group for statistical analysis. Significant p-value showed in bold. |
| Table 3: Frequency distribution of IUCD, Use of contraception and STD in partners in bacterial vaginosis cases and healthy controls. |
